Rank | Gene Set | Z-score |
---|---|---|
1 | detection of molecule of bacterial origin (GO:0032490) | 5.53516779 |
2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.93841132 |
3 | microglial cell activation (GO:0001774) | 4.66716870 |
4 | detection of external biotic stimulus (GO:0098581) | 4.36395923 |
5 | detection of other organism (GO:0098543) | 4.19214130 |
6 | cellular extravasation (GO:0045123) | 4.10352969 |
7 | macrophage activation (GO:0042116) | 4.02642591 |
8 | response to host immune response (GO:0052572) | 4.01841115 |
9 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.01841115 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98632765 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.98632765 |
12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91119112 |
13 | neutrophil mediated immunity (GO:0002446) | 3.89903614 |
14 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.86738647 |
15 | detection of biotic stimulus (GO:0009595) | 3.86434657 |
16 | neutrophil activation involved in immune response (GO:0002283) | 3.83905344 |
17 | negative regulation of B cell proliferation (GO:0030889) | 3.80807026 |
18 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.74295793 |
19 | response to host (GO:0075136) | 3.73669859 |
20 | response to host defenses (GO:0052200) | 3.73669859 |
21 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.73669859 |
22 | B cell receptor signaling pathway (GO:0050853) | 3.69508515 |
23 | negative regulation of interleukin-12 production (GO:0032695) | 3.67754617 |
24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.67416850 |
25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.66881577 |
26 | protein targeting to Golgi (GO:0000042) | 3.62017778 |
27 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.61144892 |
28 | establishment of protein localization to Golgi (GO:0072600) | 3.57388784 |
29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.57231357 |
30 | detection of bacterium (GO:0016045) | 3.57197112 |
31 | response to peptidoglycan (GO:0032494) | 3.56533023 |
32 | myeloid leukocyte mediated immunity (GO:0002444) | 3.53825757 |
33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48578811 |
34 | myeloid cell activation involved in immune response (GO:0002275) | 3.45847663 |
35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.44174480 |
36 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.42527262 |
37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.42217655 |
38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.41944694 |
39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.40906829 |
40 | protein carboxylation (GO:0018214) | 3.40906829 |
41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.38305624 |
42 | regulation of B cell differentiation (GO:0045577) | 3.36515604 |
43 | response to interleukin-15 (GO:0070672) | 3.35718082 |
44 | complement activation, alternative pathway (GO:0006957) | 3.32124161 |
45 | negative T cell selection (GO:0043383) | 3.31161586 |
46 | negative thymic T cell selection (GO:0045060) | 3.26752145 |
47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25609485 |
48 | neutrophil activation (GO:0042119) | 3.25284302 |
49 | regulation of protein activation cascade (GO:2000257) | 3.20919834 |
50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20510622 |
51 | phospholipid homeostasis (GO:0055091) | 3.20304819 |
52 | cellular response to ethanol (GO:0071361) | 3.17336345 |
53 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.16970846 |
54 | alpha-linolenic acid metabolic process (GO:0036109) | 3.15235993 |
55 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.14267536 |
56 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.14025116 |
57 | cellular response to interleukin-15 (GO:0071350) | 3.13126133 |
58 | positive T cell selection (GO:0043368) | 3.12696204 |
59 | plasma lipoprotein particle assembly (GO:0034377) | 3.12665392 |
60 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.10672604 |
61 | regulation of complement activation (GO:0030449) | 3.08958312 |
62 | leukocyte aggregation (GO:0070486) | 3.07557266 |
63 | phospholipid efflux (GO:0033700) | 3.07386240 |
64 | histone H3-K36 demethylation (GO:0070544) | 3.04314585 |
65 | urea cycle (GO:0000050) | 3.03193157 |
66 | urea metabolic process (GO:0019627) | 3.03193157 |
67 | protein-lipid complex assembly (GO:0065005) | 2.99464511 |
68 | negative regulation of adaptive immune response (GO:0002820) | 2.98362326 |
69 | respiratory burst (GO:0045730) | 2.97648955 |
70 | granulocyte activation (GO:0036230) | 2.97311091 |
71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.97106480 |
72 | positive regulation of granulocyte differentiation (GO:0030854) | 2.95812794 |
73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.94821194 |
74 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93987385 |
75 | regulation of triglyceride catabolic process (GO:0010896) | 2.92127639 |
76 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.90504028 |
77 | L-phenylalanine catabolic process (GO:0006559) | 2.88506441 |
78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.88506441 |
79 | growth hormone receptor signaling pathway (GO:0060396) | 2.87910412 |
80 | dendritic cell migration (GO:0036336) | 2.86472137 |
81 | aromatic amino acid family catabolic process (GO:0009074) | 2.86339510 |
82 | immunoglobulin mediated immune response (GO:0016064) | 2.85350283 |
83 | negative regulation of sterol transport (GO:0032372) | 2.85105680 |
84 | negative regulation of cholesterol transport (GO:0032375) | 2.85105680 |
85 | I-kappaB phosphorylation (GO:0007252) | 2.80793669 |
86 | T cell migration (GO:0072678) | 2.80786809 |
87 | bile acid and bile salt transport (GO:0015721) | 2.80192088 |
88 | cellular response to type I interferon (GO:0071357) | 2.79889979 |
89 | type I interferon signaling pathway (GO:0060337) | 2.79889979 |
90 | regulation of cholesterol homeostasis (GO:2000188) | 2.79740208 |
91 | response to type I interferon (GO:0034340) | 2.78898996 |
92 | tryptophan catabolic process (GO:0006569) | 2.77974118 |
93 | indole-containing compound catabolic process (GO:0042436) | 2.77974118 |
94 | indolalkylamine catabolic process (GO:0046218) | 2.77974118 |
95 | negative regulation of fibrinolysis (GO:0051918) | 2.77055548 |
96 | positive regulation of interferon-beta production (GO:0032728) | 2.75900716 |
97 | myeloid leukocyte activation (GO:0002274) | 2.75322433 |
98 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.74686986 |
99 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74453231 |
100 | high-density lipoprotein particle remodeling (GO:0034375) | 2.73485955 |
101 | positive regulation of mast cell activation (GO:0033005) | 2.73478943 |
102 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.72899430 |
103 | negative regulation of B cell mediated immunity (GO:0002713) | 2.72899430 |
104 | positive regulation by symbiont of host defense response (GO:0052509) | 2.72419792 |
105 | modulation by symbiont of host defense response (GO:0052031) | 2.72419792 |
106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.72419792 |
107 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.72419792 |
108 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.72419792 |
109 | modulation by symbiont of host immune response (GO:0052553) | 2.72419792 |
110 | interferon-gamma production (GO:0032609) | 2.71807366 |
111 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.71607319 |
112 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.71445254 |
113 | cholesterol efflux (GO:0033344) | 2.71195690 |
114 | tryptophan metabolic process (GO:0006568) | 2.70787210 |
115 | reverse cholesterol transport (GO:0043691) | 2.70236174 |
116 | T-helper 1 type immune response (GO:0042088) | 2.69304567 |
117 | kynurenine metabolic process (GO:0070189) | 2.68789147 |
118 | positive regulation of histone deacetylation (GO:0031065) | 2.68082020 |
119 | defense response to protozoan (GO:0042832) | 2.65961824 |
120 | plasma lipoprotein particle clearance (GO:0034381) | 2.65781368 |
121 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.65319413 |
122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63161698 |
123 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.63046867 |
124 | nitrogen cycle metabolic process (GO:0071941) | 2.63040782 |
125 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.63011542 |
126 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.63011542 |
127 | positive regulation of lipid catabolic process (GO:0050996) | 2.62319962 |
128 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.61307311 |
129 | response to laminar fluid shear stress (GO:0034616) | 2.60230117 |
130 | L-phenylalanine metabolic process (GO:0006558) | 2.58626577 |
131 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.58626577 |
132 | bile acid biosynthetic process (GO:0006699) | 2.58391020 |
133 | protein-lipid complex remodeling (GO:0034368) | 2.57914528 |
134 | macromolecular complex remodeling (GO:0034367) | 2.57914528 |
135 | plasma lipoprotein particle remodeling (GO:0034369) | 2.57914528 |
136 | cysteine metabolic process (GO:0006534) | 2.56882642 |
137 | positive regulation of B cell differentiation (GO:0045579) | 2.56031785 |
138 | regulation of fibrinolysis (GO:0051917) | 2.55968832 |
139 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.54300401 |
140 | definitive hemopoiesis (GO:0060216) | 2.54031587 |
141 | bile acid metabolic process (GO:0008206) | 2.52944495 |
142 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.52793935 |
143 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.52657174 |
144 | positive thymic T cell selection (GO:0045059) | 2.52051742 |
145 | plasma lipoprotein particle organization (GO:0071827) | 2.51845027 |
146 | regulation of cholesterol storage (GO:0010885) | 2.50766509 |
147 | positive regulation of interferon-alpha production (GO:0032727) | 2.49154188 |
148 | hepatocyte apoptotic process (GO:0097284) | 2.48481146 |
149 | protein-lipid complex subunit organization (GO:0071825) | 2.48103894 |
150 | homocysteine metabolic process (GO:0050667) | 2.44495802 |
151 | lysine catabolic process (GO:0006554) | 2.44279058 |
152 | lysine metabolic process (GO:0006553) | 2.44279058 |
153 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.41472163 |
154 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.41099756 |
155 | low-density lipoprotein particle clearance (GO:0034383) | 2.41018702 |
156 | positive regulation of p38MAPK cascade (GO:1900745) | 2.40263670 |
157 | regulation of interferon-alpha production (GO:0032647) | 2.40109553 |
158 | positive regulation of glycolytic process (GO:0045821) | 2.39767274 |
159 | cellular response to growth hormone stimulus (GO:0071378) | 2.39608433 |
160 | fibrinolysis (GO:0042730) | 2.38416780 |
161 | triglyceride homeostasis (GO:0070328) | 2.37936414 |
162 | acylglycerol homeostasis (GO:0055090) | 2.37936414 |
163 | negative regulation of protein activation cascade (GO:2000258) | 2.37363081 |
164 | lipoprotein metabolic process (GO:0042157) | 2.36186568 |
165 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.35913103 |
166 | macrophage activation involved in immune response (GO:0002281) | 2.35812885 |
167 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.35452040 |
168 | sulfur amino acid catabolic process (GO:0000098) | 2.34903536 |
169 | negative regulation of cell killing (GO:0031342) | 2.34140202 |
170 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.34140202 |
171 | negative regulation of lipid storage (GO:0010888) | 2.33706185 |
172 | intestinal cholesterol absorption (GO:0030299) | 2.33163412 |
173 | cholesterol homeostasis (GO:0042632) | 2.32696733 |
174 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.31744977 |
175 | sterol homeostasis (GO:0055092) | 2.30813762 |
176 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.29044884 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.64619532 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.08067581 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.87289752 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42407840 |
5 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.39807704 |
6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.32495829 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15000763 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.10772409 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.99955836 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.96973071 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.80122750 |
12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.75218791 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.54491774 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40257133 |
15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.36127902 |
16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36106172 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25202373 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23273144 |
19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22842750 |
20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17338785 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.12407594 |
22 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08854368 |
23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.04416043 |
24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.02657840 |
25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95062353 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87101860 |
27 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85525874 |
28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84433040 |
29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81410879 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76050383 |
31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.69594670 |
32 | GATA1_19941826_ChIP-Seq_K562_Human | 1.66994142 |
33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.66687739 |
34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.65901104 |
35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64668190 |
36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.64325248 |
37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62114290 |
38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60806158 |
39 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56626403 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52697652 |
41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52307266 |
42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51949121 |
43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49787476 |
44 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47820320 |
45 | MAF_26560356_Chip-Seq_TH1_Human | 1.46603780 |
46 | GATA2_19941826_ChIP-Seq_K562_Human | 1.46368277 |
47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45699797 |
48 | MYB_26560356_Chip-Seq_TH2_Human | 1.45079949 |
49 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42205386 |
50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41550899 |
51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41305765 |
52 | MYB_26560356_Chip-Seq_TH1_Human | 1.40145836 |
53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38760945 |
54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33102311 |
55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30654218 |
56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30021496 |
57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29789159 |
58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28898410 |
59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28370057 |
60 | MYC_22102868_ChIP-Seq_BL_Human | 1.27619782 |
61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27396140 |
62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22540154 |
63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20940547 |
64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18866411 |
65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18401858 |
66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17049974 |
67 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16639438 |
68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16357103 |
69 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.15570475 |
70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15072211 |
71 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14942703 |
72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14652345 |
73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14458911 |
74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14419739 |
75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14119378 |
76 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13796183 |
77 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13765066 |
78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13535780 |
79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12743198 |
80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11495648 |
81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10567358 |
82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10512394 |
83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10378746 |
84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09830129 |
85 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08502212 |
86 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08437163 |
87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08077379 |
88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07385166 |
89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06908164 |
90 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.06668831 |
91 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.06665452 |
92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05785303 |
93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05741655 |
94 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05013445 |
95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04564670 |
96 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04145463 |
97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03982486 |
98 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03835200 |
99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03504546 |
100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02908754 |
101 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.02872675 |
102 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01164760 |
103 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.01077114 |
104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00813677 |
105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00122955 |
106 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98786582 |
107 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98403520 |
108 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97267076 |
109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96532057 |
110 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95206668 |
111 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94652215 |
112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94401155 |
113 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94294264 |
114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94294264 |
115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93367560 |
116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93081132 |
117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92722732 |
118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92722732 |
119 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92166275 |
120 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91408068 |
121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91313817 |
122 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89719381 |
123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89708760 |
124 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89708535 |
125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89544377 |
126 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89362998 |
127 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87037987 |
128 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87011754 |
129 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86164955 |
130 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.85604643 |
131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85427378 |
132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85312787 |
133 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85258888 |
134 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85156476 |
135 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.85062496 |
136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84999732 |
137 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83675211 |
138 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82888060 |
139 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82266417 |
140 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81970739 |
141 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.81970739 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.97841776 |
2 | MP0005360_urolithiasis | 3.88321785 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.02045198 |
4 | MP0005365_abnormal_bile_salt | 3.01316417 |
5 | MP0003252_abnormal_bile_duct | 2.88464293 |
6 | MP0003300_gastrointestinal_ulcer | 2.65667068 |
7 | MP0008260_abnormal_autophagy | 2.39143405 |
8 | MP0003191_abnormal_cellular_cholesterol | 2.34236997 |
9 | MP0001835_abnormal_antigen_presentation | 2.16301896 |
10 | MP0005451_abnormal_body_composition | 2.09748006 |
11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.04139763 |
12 | MP0002138_abnormal_hepatobiliary_system | 2.01765122 |
13 | MP0003656_abnormal_erythrocyte_physiolo | 2.01431541 |
14 | MP0003705_abnormal_hypodermis_morpholog | 1.97883683 |
15 | MP0004883_abnormal_blood_vessel | 1.97602225 |
16 | MP0003436_decreased_susceptibility_to | 1.97085868 |
17 | MP0003303_peritoneal_inflammation | 1.97005133 |
18 | MP0010329_abnormal_lipoprotein_level | 1.95131009 |
19 | MP0009840_abnormal_foam_cell | 1.91349668 |
20 | MP0002166_altered_tumor_susceptibility | 1.89303760 |
21 | MP0008057_abnormal_DNA_replication | 1.87684789 |
22 | MP0005310_abnormal_salivary_gland | 1.83648885 |
23 | MP0009278_abnormal_bone_marrow | 1.82320226 |
24 | MP0004381_abnormal_hair_follicle | 1.82145046 |
25 | MP0000015_abnormal_ear_pigmentation | 1.78638678 |
26 | MP0003724_increased_susceptibility_to | 1.75062810 |
27 | MP0000685_abnormal_immune_system | 1.74506089 |
28 | MP0001790_abnormal_immune_system | 1.73953121 |
29 | MP0005387_immune_system_phenotype | 1.73953121 |
30 | MP0005464_abnormal_platelet_physiology | 1.73514640 |
31 | MP0001800_abnormal_humoral_immune | 1.72882700 |
32 | MP0001666_abnormal_nutrient_absorption | 1.71333752 |
33 | MP0000569_abnormal_digit_pigmentation | 1.70903546 |
34 | MP0004947_skin_inflammation | 1.70615027 |
35 | MP0000609_abnormal_liver_physiology | 1.62096105 |
36 | MP0002419_abnormal_innate_immunity | 1.60902353 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.59469906 |
38 | MP0001545_abnormal_hematopoietic_system | 1.59469906 |
39 | MP0002254_reproductive_system_inflammat | 1.58265015 |
40 | MP0005671_abnormal_response_to | 1.56947051 |
41 | MP0005164_abnormal_response_to | 1.53526318 |
42 | MP0002132_abnormal_respiratory_system | 1.50945976 |
43 | MP0002452_abnormal_antigen_presenting | 1.50601172 |
44 | MP0005025_abnormal_response_to | 1.50189891 |
45 | MP0003172_abnormal_lysosome_physiology | 1.49577284 |
46 | MP0009785_altered_susceptibility_to | 1.48280359 |
47 | MP0010155_abnormal_intestine_physiology | 1.46129166 |
48 | MP0003183_abnormal_peptide_metabolism | 1.46024822 |
49 | MP0002009_preneoplasia | 1.43893945 |
50 | MP0005000_abnormal_immune_tolerance | 1.41615854 |
51 | MP0005410_abnormal_fertilization | 1.41292491 |
52 | MP0002396_abnormal_hematopoietic_system | 1.39691566 |
53 | MP0003787_abnormal_imprinting | 1.39296824 |
54 | MP0010368_abnormal_lymphatic_system | 1.38914683 |
55 | MP0002723_abnormal_immune_serum | 1.38117342 |
56 | MP0010352_gastrointestinal_tract_polyps | 1.37251412 |
57 | MP0003868_abnormal_feces_composition | 1.34556153 |
58 | MP0001873_stomach_inflammation | 1.34093711 |
59 | MP0009764_decreased_sensitivity_to | 1.30053057 |
60 | MP0006082_CNS_inflammation | 1.28227080 |
61 | MP0001845_abnormal_inflammatory_respons | 1.28059634 |
62 | MP0001819_abnormal_immune_cell | 1.27143918 |
63 | MP0003566_abnormal_cell_adhesion | 1.27035145 |
64 | MP0002420_abnormal_adaptive_immunity | 1.27003006 |
65 | MP0004808_abnormal_hematopoietic_stem | 1.26412896 |
66 | MP0001533_abnormal_skeleton_physiology | 1.24704986 |
67 | MP0000703_abnormal_thymus_morphology | 1.24266782 |
68 | MP0002006_tumorigenesis | 1.21915091 |
69 | MP0005083_abnormal_biliary_tract | 1.21214256 |
70 | MP0005075_abnormal_melanosome_morpholog | 1.19733313 |
71 | MP0003866_abnormal_defecation | 1.18410149 |
72 | MP0008469_abnormal_protein_level | 1.17693777 |
73 | MP0001853_heart_inflammation | 1.17397903 |
74 | MP0002398_abnormal_bone_marrow | 1.17228371 |
75 | MP0006054_spinal_hemorrhage | 1.14937054 |
76 | MP0002118_abnormal_lipid_homeostasis | 1.14357349 |
77 | MP0002405_respiratory_system_inflammati | 1.14235114 |
78 | MP0010234_abnormal_vibrissa_follicle | 1.13462263 |
79 | MP0003763_abnormal_thymus_physiology | 1.11927157 |
80 | MP0004147_increased_porphyrin_level | 1.11786306 |
81 | MP0005023_abnormal_wound_healing | 1.09159055 |
82 | MP0000465_gastrointestinal_hemorrhage | 1.09092982 |
83 | MP0005174_abnormal_tail_pigmentation | 1.08392437 |
84 | MP0000716_abnormal_immune_system | 1.08176221 |
85 | MP0004130_abnormal_muscle_cell | 1.08026334 |
86 | MP0009763_increased_sensitivity_to | 1.06511964 |
87 | MP0005076_abnormal_cell_differentiation | 1.04379633 |
88 | MP0003453_abnormal_keratinocyte_physiol | 1.03554321 |
89 | MP0000371_diluted_coat_color | 1.03402247 |
90 | MP0000858_altered_metastatic_potential | 1.02688232 |
91 | MP0003806_abnormal_nucleotide_metabolis | 1.02607699 |
92 | MP0000598_abnormal_liver_morphology | 1.02298061 |
93 | MP0002877_abnormal_melanocyte_morpholog | 1.00505364 |
94 | MP0001879_abnormal_lymphatic_vessel | 0.99834457 |
95 | MP0004484_altered_response_of | 0.99164758 |
96 | MP0005319_abnormal_enzyme/_coenzyme | 0.98322177 |
97 | MP0002148_abnormal_hypersensitivity_rea | 0.98274970 |
98 | MP0000689_abnormal_spleen_morphology | 0.97941735 |
99 | MP0002928_abnormal_bile_duct | 0.97452745 |
100 | MP0003045_fibrosis | 0.97222891 |
101 | MP0010307_abnormal_tumor_latency | 0.96890699 |
102 | MP0008438_abnormal_cutaneous_collagen | 0.94672634 |
103 | MP0002332_abnormal_exercise_endurance | 0.94651549 |
104 | MP0008004_abnormal_stomach_pH | 0.94498679 |
105 | MP0005058_abnormal_lysosome_morphology | 0.94392443 |
106 | MP0008877_abnormal_DNA_methylation | 0.93964043 |
107 | MP0003091_abnormal_cell_migration | 0.93837699 |
108 | MP0004264_abnormal_extraembryonic_tissu | 0.93773266 |
109 | MP0002722_abnormal_immune_system | 0.93404113 |
110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93352485 |
111 | MP0009333_abnormal_splenocyte_physiolog | 0.93251507 |
112 | MP0002429_abnormal_blood_cell | 0.93189750 |
113 | MP0002060_abnormal_skin_morphology | 0.91587125 |
114 | MP0003943_abnormal_hepatobiliary_system | 0.86958174 |
115 | MP0002998_abnormal_bone_remodeling | 0.86725190 |
116 | MP0000249_abnormal_blood_vessel | 0.86435388 |
117 | MP0003195_calcinosis | 0.86148963 |
118 | MP0009643_abnormal_urine_homeostasis | 0.85569805 |
119 | MP0004510_myositis | 0.84711739 |
120 | MP0001243_abnormal_dermal_layer | 0.83355393 |
121 | MP0003448_altered_tumor_morphology | 0.82220498 |
122 | MP0005408_hypopigmentation | 0.80319352 |
123 | MP0003828_pulmonary_edema | 0.78948622 |
124 | MP0002933_joint_inflammation | 0.78690145 |
125 | MP0004019_abnormal_vitamin_homeostasis | 0.77832124 |
126 | MP0003075_altered_response_to | 0.77673681 |
127 | MP0000767_abnormal_smooth_muscle | 0.77600115 |
128 | MP0002136_abnormal_kidney_physiology | 0.76223405 |
129 | MP0001851_eye_inflammation | 0.76109874 |
130 | MP0005376_homeostasis/metabolism_phenot | 0.73870768 |
131 | MP0005166_decreased_susceptibility_to | 0.71854569 |
132 | MP0003690_abnormal_glial_cell | 0.70676121 |
133 | MP0009115_abnormal_fat_cell | 0.70337837 |
134 | MP0000604_amyloidosis | 0.69853021 |
135 | MP0009765_abnormal_xenobiotic_induced | 0.68445149 |
136 | MP0000427_abnormal_hair_cycle | 0.67915547 |
137 | MP0002277_abnormal_respiratory_mucosa | 0.60528029 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Optic neuritis (HP:0100653) | 4.72659163 |
2 | Retrobulbar optic neuritis (HP:0100654) | 4.72659163 |
3 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.60795600 |
4 | Deep venous thrombosis (HP:0002625) | 4.18047163 |
5 | Stomatitis (HP:0010280) | 3.97810434 |
6 | Intrahepatic cholestasis (HP:0001406) | 3.79439163 |
7 | Complement deficiency (HP:0004431) | 3.65310185 |
8 | Keratoconjunctivitis sicca (HP:0001097) | 3.58528176 |
9 | Myocardial infarction (HP:0001658) | 3.57867737 |
10 | Abnormality of macrophages (HP:0004311) | 3.52522106 |
11 | Xanthomatosis (HP:0000991) | 3.49606862 |
12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.48355588 |
13 | Keratoconjunctivitis (HP:0001096) | 3.34375919 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 3.33308049 |
15 | Meningitis (HP:0001287) | 3.21291401 |
16 | Acanthocytosis (HP:0001927) | 3.17895777 |
17 | Mitral stenosis (HP:0001718) | 3.16940884 |
18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.15456880 |
19 | Gingival bleeding (HP:0000225) | 3.08769435 |
20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.08128379 |
21 | Joint hemorrhage (HP:0005261) | 3.03960892 |
22 | Prolonged partial thromboplastin time (HP:0003645) | 3.03515803 |
23 | Chest pain (HP:0100749) | 3.03046532 |
24 | Eczematoid dermatitis (HP:0000976) | 3.00868677 |
25 | Encephalitis (HP:0002383) | 2.99975170 |
26 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98152020 |
27 | Spontaneous hematomas (HP:0007420) | 2.97475873 |
28 | Abnormality of the fingertips (HP:0001211) | 2.95470616 |
29 | Poikilocytosis (HP:0004447) | 2.93820658 |
30 | Autoimmune thrombocytopenia (HP:0001973) | 2.90873927 |
31 | Abnormality of T cells (HP:0002843) | 2.88459432 |
32 | Systemic lupus erythematosus (HP:0002725) | 2.86179479 |
33 | Recurrent bronchitis (HP:0002837) | 2.85219392 |
34 | Hyperlipoproteinemia (HP:0010980) | 2.83849633 |
35 | Hemoptysis (HP:0002105) | 2.78745186 |
36 | Colitis (HP:0002583) | 2.78590749 |
37 | Hypochromic microcytic anemia (HP:0004840) | 2.77901361 |
38 | Esophageal varix (HP:0002040) | 2.75460295 |
39 | Urticaria (HP:0001025) | 2.73972559 |
40 | Hematochezia (HP:0002573) | 2.73100852 |
41 | Recurrent viral infections (HP:0004429) | 2.73030585 |
42 | Obstructive lung disease (HP:0006536) | 2.71812539 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71812539 |
44 | Resting tremor (HP:0002322) | 2.71289060 |
45 | Abnormality of complement system (HP:0005339) | 2.71131876 |
46 | Pulmonary infiltrates (HP:0002113) | 2.70440940 |
47 | Epidermoid cyst (HP:0200040) | 2.69008441 |
48 | Polycythemia (HP:0001901) | 2.66257329 |
49 | Recurrent fungal infections (HP:0002841) | 2.65428814 |
50 | Recurrent bacterial skin infections (HP:0005406) | 2.64867078 |
51 | Hypobetalipoproteinemia (HP:0003563) | 2.64221387 |
52 | Gangrene (HP:0100758) | 2.57365131 |
53 | Hypercholesterolemia (HP:0003124) | 2.53295921 |
54 | Abnormal platelet volume (HP:0011876) | 2.45832750 |
55 | Pustule (HP:0200039) | 2.45607770 |
56 | Osteomyelitis (HP:0002754) | 2.44787405 |
57 | Increased mean platelet volume (HP:0011877) | 2.44122731 |
58 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.43251388 |
59 | Acute hepatic failure (HP:0006554) | 2.42560733 |
60 | Autoimmune hemolytic anemia (HP:0001890) | 2.42505378 |
61 | Epistaxis (HP:0000421) | 2.42142537 |
62 | Hypoalphalipoproteinemia (HP:0003233) | 2.40537304 |
63 | Aortic aneurysm (HP:0004942) | 2.39883860 |
64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.39868467 |
65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.37857275 |
66 | Periodontitis (HP:0000704) | 2.37585286 |
67 | Recurrent abscess formation (HP:0002722) | 2.36349720 |
68 | Hypolipoproteinemia (HP:0010981) | 2.35391149 |
69 | Hepatocellular carcinoma (HP:0001402) | 2.33682997 |
70 | Prolonged bleeding time (HP:0003010) | 2.30468601 |
71 | Anorexia (HP:0002039) | 2.30258700 |
72 | Abnormal platelet function (HP:0011869) | 2.29823135 |
73 | Impaired platelet aggregation (HP:0003540) | 2.29823135 |
74 | Papillary thyroid carcinoma (HP:0002895) | 2.29592351 |
75 | Inflammation of the large intestine (HP:0002037) | 2.29403798 |
76 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.28280771 |
77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.25527239 |
78 | Recurrent pneumonia (HP:0006532) | 2.24740418 |
79 | Menorrhagia (HP:0000132) | 2.23821852 |
80 | Abnormality of the peritoneum (HP:0002585) | 2.23315252 |
81 | Lymphopenia (HP:0001888) | 2.21565554 |
82 | Glomerulonephritis (HP:0000099) | 2.20081335 |
83 | Abnormality of eosinophils (HP:0001879) | 2.18096852 |
84 | Hemorrhage of the eye (HP:0011885) | 2.15271700 |
85 | Verrucae (HP:0200043) | 2.13650679 |
86 | Papilloma (HP:0012740) | 2.13650679 |
87 | Recurrent skin infections (HP:0001581) | 2.12553137 |
88 | Nephritis (HP:0000123) | 2.11730977 |
89 | Viral hepatitis (HP:0006562) | 2.11642238 |
90 | Gastrointestinal inflammation (HP:0004386) | 2.11344645 |
91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11036836 |
92 | Osteolytic defects of the hand bones (HP:0009699) | 2.10786361 |
93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10786361 |
94 | Chronic diarrhea (HP:0002028) | 2.10760538 |
95 | Cerebral aneurysm (HP:0004944) | 2.08599522 |
96 | Pulmonary embolism (HP:0002204) | 2.08375170 |
97 | Thyroiditis (HP:0100646) | 2.06494154 |
98 | Hypoglycemic coma (HP:0001325) | 2.06214998 |
99 | Fat malabsorption (HP:0002630) | 2.04255340 |
100 | Arterial thrombosis (HP:0004420) | 2.04171652 |
101 | Thrombophlebitis (HP:0004418) | 2.03979185 |
102 | Keratitis (HP:0000491) | 2.02618487 |
103 | Granulocytopenia (HP:0001913) | 2.02611685 |
104 | T lymphocytopenia (HP:0005403) | 2.02512235 |
105 | Abnormality of T cell physiology (HP:0011840) | 2.02355927 |
106 | Sepsis (HP:0100806) | 2.01451690 |
107 | Amaurosis fugax (HP:0100576) | 2.01449043 |
108 | Cellulitis (HP:0100658) | 1.99038601 |
109 | Amyloidosis (HP:0011034) | 1.98797598 |
110 | Chronic otitis media (HP:0000389) | 1.98614586 |
111 | Slow saccadic eye movements (HP:0000514) | 1.98491272 |
112 | Agammaglobulinemia (HP:0004432) | 1.98208540 |
113 | Episodic fever (HP:0001954) | 1.97994129 |
114 | Abnormality of T cell number (HP:0011839) | 1.97203343 |
115 | Subacute progressive viral hepatitis (HP:0006572) | 1.95916519 |
116 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94998509 |
117 | Abnormality of the pleura (HP:0002103) | 1.92203321 |
118 | IgM deficiency (HP:0002850) | 1.90215679 |
119 | Glomerulopathy (HP:0100820) | 1.89158864 |
120 | Fatigue (HP:0012378) | 1.88100999 |
121 | Bronchitis (HP:0012387) | 1.86776976 |
122 | Volvulus (HP:0002580) | 1.86298786 |
123 | Vasculitis (HP:0002633) | 1.85444011 |
124 | Hypochromic anemia (HP:0001931) | 1.85138021 |
125 | Hyperbilirubinemia (HP:0002904) | 1.84649906 |
126 | Abnormality of iron homeostasis (HP:0011031) | 1.83402945 |
127 | Thick nail (HP:0001805) | 1.83211369 |
128 | Hepatitis (HP:0012115) | 1.82422298 |
129 | Mitral valve prolapse (HP:0001634) | 1.81231609 |
130 | Abnormality of the endocardium (HP:0004306) | 1.80549533 |
131 | Myositis (HP:0100614) | 1.80037457 |
132 | Postural instability (HP:0002172) | 1.79845395 |
133 | Menstrual irregularities (HP:0000858) | 1.79493377 |
134 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.79353217 |
135 | Peritonitis (HP:0002586) | 1.79239869 |
136 | Alveolar cell carcinoma (HP:0006519) | 1.78519681 |
137 | Gastrointestinal infarctions (HP:0005244) | 1.78347898 |
138 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77951489 |
139 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77951489 |
140 | Abnormality of the nasal mucosa (HP:0000433) | 1.77865399 |
141 | Vertigo (HP:0002321) | 1.76587430 |
142 | Interstitial pulmonary disease (HP:0006530) | 1.76440966 |
143 | IgA deficiency (HP:0002720) | 1.76327845 |
144 | Eosinophilia (HP:0001880) | 1.76284719 |
145 | Skin ulcer (HP:0200042) | 1.75904739 |
146 | Panhypogammaglobulinemia (HP:0003139) | 1.75505666 |
147 | Disproportionate tall stature (HP:0001519) | 1.74947045 |
148 | Hyperammonemia (HP:0001987) | 1.74414088 |
149 | Reticulocytosis (HP:0001923) | 1.73894418 |
150 | Increased IgE level (HP:0003212) | 1.73768338 |
151 | Hypoplasia of the thymus (HP:0000778) | 1.73577143 |
152 | Conjunctival telangiectasia (HP:0000524) | 1.72610471 |
153 | Leukocytosis (HP:0001974) | 1.72362886 |
154 | Orchitis (HP:0100796) | 1.72017598 |
155 | Gingivitis (HP:0000230) | 1.70531313 |
156 | Spontaneous abortion (HP:0005268) | 1.70478175 |
157 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.68417590 |
158 | Acute myeloid leukemia (HP:0004808) | 1.67462780 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 2.74178607 |
2 | MAP4K1 | 2.67158135 |
3 | TYK2 | 2.67014300 |
4 | FGFR4 | 2.58343468 |
5 | TAOK3 | 2.53246128 |
6 | TGFBR2 | 2.41747201 |
7 | JAK1 | 2.25199540 |
8 | CAMK1D | 2.21674213 |
9 | BMPR2 | 2.17751271 |
10 | MAP3K14 | 2.11050885 |
11 | STK10 | 1.96890582 |
12 | EPHB1 | 1.94854161 |
13 | MAP3K10 | 1.92192213 |
14 | PTK6 | 1.91313919 |
15 | SIK1 | 1.86646883 |
16 | TXK | 1.84696915 |
17 | TRIB3 | 1.84626617 |
18 | FGFR3 | 1.81687937 |
19 | IRAK1 | 1.81613185 |
20 | JAK3 | 1.81100870 |
21 | CDK12 | 1.76730048 |
22 | FGR | 1.76553132 |
23 | CAMK1G | 1.74939505 |
24 | RIPK1 | 1.69207427 |
25 | TBK1 | 1.66308442 |
26 | FES | 1.63100341 |
27 | MAP3K2 | 1.61840738 |
28 | FRK | 1.60691111 |
29 | IKBKE | 1.55634841 |
30 | KIT | 1.54008465 |
31 | ITK | 1.50017699 |
32 | PKN2 | 1.49484384 |
33 | EPHA3 | 1.48400105 |
34 | CDK6 | 1.46108792 |
35 | INSRR | 1.45943558 |
36 | AKT3 | 1.44173029 |
37 | CSK | 1.43187392 |
38 | IRAK2 | 1.42540390 |
39 | WNK1 | 1.41762881 |
40 | ZAP70 | 1.41155124 |
41 | MAP3K3 | 1.35835235 |
42 | YES1 | 1.31897357 |
43 | TIE1 | 1.31476884 |
44 | STK3 | 1.29355147 |
45 | CHUK | 1.24944360 |
46 | MAP3K7 | 1.24123399 |
47 | BRD4 | 1.24025676 |
48 | JAK2 | 1.23180075 |
49 | ACVR1B | 1.22626474 |
50 | TEC | 1.20180034 |
51 | NEK9 | 1.19712141 |
52 | PTK2B | 1.16066132 |
53 | MST1R | 1.12444005 |
54 | CAMKK2 | 1.12192249 |
55 | TNK2 | 1.09647566 |
56 | MAP2K3 | 1.07649999 |
57 | CSF1R | 1.06401995 |
58 | LRRK2 | 1.04859212 |
59 | GRK6 | 1.03570837 |
60 | IKBKB | 1.02552191 |
61 | TTN | 1.01483912 |
62 | MAP3K13 | 1.01181243 |
63 | BTK | 0.99090199 |
64 | MAP3K1 | 0.98152225 |
65 | HCK | 0.97843544 |
66 | IRAK4 | 0.94539762 |
67 | FLT3 | 0.92273485 |
68 | NUAK1 | 0.91978405 |
69 | SGK3 | 0.91276730 |
70 | PLK2 | 0.88118853 |
71 | PRKCH | 0.88113690 |
72 | PDGFRB | 0.88022585 |
73 | IRAK3 | 0.87282232 |
74 | KSR2 | 0.86201551 |
75 | PIM1 | 0.86153520 |
76 | LATS1 | 0.85466023 |
77 | SYK | 0.83875789 |
78 | PRKAA2 | 0.83722207 |
79 | FGFR2 | 0.82588653 |
80 | LCK | 0.82452595 |
81 | MAPK15 | 0.79637256 |
82 | STK38 | 0.78819142 |
83 | TRPM7 | 0.77787050 |
84 | PRKCQ | 0.77218509 |
85 | EEF2K | 0.77001890 |
86 | NLK | 0.76379966 |
87 | CDK9 | 0.75805186 |
88 | NEK6 | 0.75181497 |
89 | PRPF4B | 0.74995330 |
90 | MAPK11 | 0.73557438 |
91 | RAF1 | 0.71700901 |
92 | MARK2 | 0.71431295 |
93 | MAPK7 | 0.70735561 |
94 | TAOK1 | 0.70660818 |
95 | STK24 | 0.65688103 |
96 | KDR | 0.65307930 |
97 | MAP3K6 | 0.64661417 |
98 | MATK | 0.64315547 |
99 | EGFR | 0.63413805 |
100 | STK4 | 0.62550258 |
101 | PDGFRA | 0.62525338 |
102 | KSR1 | 0.60177828 |
103 | MARK3 | 0.59891373 |
104 | PIK3CA | 0.59434903 |
105 | MTOR | 0.59417259 |
106 | PAK3 | 0.58758629 |
107 | RET | 0.58610311 |
108 | RIPK4 | 0.58141691 |
109 | PLK4 | 0.56473928 |
110 | PDPK1 | 0.56069184 |
111 | BLK | 0.55959808 |
112 | PIK3CG | 0.55255817 |
113 | SGK223 | 0.54388092 |
114 | SGK494 | 0.54388092 |
115 | GSK3A | 0.54239822 |
116 | MAP3K5 | 0.54126072 |
117 | SIK2 | 0.53656865 |
118 | LYN | 0.53271606 |
119 | ERBB2 | 0.51664870 |
120 | HIPK2 | 0.50546620 |
121 | RPS6KA4 | 0.50092579 |
122 | IGF1R | 0.49961904 |
123 | BMX | 0.49462475 |
124 | MAPK12 | 0.48145226 |
125 | MELK | 0.47974813 |
126 | DYRK1B | 0.46787714 |
127 | CDK4 | 0.43131021 |
128 | SGK1 | 0.42988921 |
129 | CAMK4 | 0.41948738 |
130 | PDK1 | 0.40660609 |
131 | MAPK4 | 0.40409273 |
132 | TGFBR1 | 0.40270992 |
133 | SGK2 | 0.40122039 |
134 | FER | 0.38272169 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.82829944 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.81051976 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.75992464 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.73655812 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57273918 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.24365065 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.19081145 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.06181527 |
9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94398636 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.86014321 |
11 | ABC transporters_Homo sapiens_hsa02010 | 1.79752289 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63813491 |
13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59820430 |
14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59031918 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57749911 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57103175 |
17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48702356 |
18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47869177 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47107371 |
20 | Lysine degradation_Homo sapiens_hsa00310 | 1.44725260 |
21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41706553 |
22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28165028 |
23 | Bile secretion_Homo sapiens_hsa04976 | 1.28028501 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26615965 |
25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.23937424 |
26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22146562 |
27 | Measles_Homo sapiens_hsa05162 | 1.17585150 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14756911 |
29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13978352 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11539123 |
31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10311919 |
32 | Asthma_Homo sapiens_hsa05310 | 1.09385875 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08796750 |
34 | Insulin resistance_Homo sapiens_hsa04931 | 1.08721641 |
35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07668604 |
36 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03408528 |
37 | Malaria_Homo sapiens_hsa05144 | 1.02804309 |
38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02543821 |
39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01031962 |
40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.99972855 |
41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99929200 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99306205 |
43 | Phagosome_Homo sapiens_hsa04145 | 0.99214024 |
44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98418622 |
45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97709356 |
46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97571896 |
47 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97104140 |
48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93199266 |
49 | Pertussis_Homo sapiens_hsa05133 | 0.92986694 |
50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92081378 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 0.91819965 |
52 | Peroxisome_Homo sapiens_hsa04146 | 0.91267018 |
53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90890044 |
54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90880946 |
55 | Influenza A_Homo sapiens_hsa05164 | 0.90722333 |
56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90603182 |
57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90472098 |
58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89516991 |
59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86819436 |
60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85230367 |
61 | Platelet activation_Homo sapiens_hsa04611 | 0.84974846 |
62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83995220 |
63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83965099 |
64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.82455366 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81660116 |
66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81079977 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80206551 |
68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79955130 |
69 | Amoebiasis_Homo sapiens_hsa05146 | 0.78706066 |
70 | Hepatitis B_Homo sapiens_hsa05161 | 0.78232152 |
71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.77496184 |
72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77057619 |
73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76776084 |
74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76421111 |
75 | Prostate cancer_Homo sapiens_hsa05215 | 0.75805097 |
76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72283895 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72281116 |
78 | Tuberculosis_Homo sapiens_hsa05152 | 0.71468253 |
79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70844912 |
80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70759212 |
81 | Apoptosis_Homo sapiens_hsa04210 | 0.70620794 |
82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70441046 |
83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70276172 |
84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70095533 |
85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69660741 |
86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68505153 |
87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67780389 |
88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66750628 |
89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66663252 |
90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66513226 |
91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65036532 |
92 | Shigellosis_Homo sapiens_hsa05131 | 0.64774439 |
93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63739968 |
94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63004361 |
95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62785259 |
96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62703395 |
97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61952736 |
98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61743673 |
99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61120523 |
100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60934784 |
101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60375356 |
102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59989218 |
103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59346435 |
104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59293083 |
105 | Legionellosis_Homo sapiens_hsa05134 | 0.58425670 |
106 | Adherens junction_Homo sapiens_hsa04520 | 0.57107830 |
107 | Salmonella infection_Homo sapiens_hsa05132 | 0.56273819 |
108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55339239 |
109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55192737 |
110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54751345 |
111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54500823 |
112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54329147 |
113 | Endocytosis_Homo sapiens_hsa04144 | 0.53476873 |
114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52660329 |
115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52517968 |
116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51670351 |
117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51536350 |
118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50779392 |
119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49249445 |
120 | Focal adhesion_Homo sapiens_hsa04510 | 0.49015606 |
121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48935392 |
122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47762135 |
123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47478319 |
124 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47355438 |
125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46921211 |
126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46856926 |
127 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46216090 |
128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45442375 |
129 | Glioma_Homo sapiens_hsa05214 | 0.45246357 |
130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43252491 |
131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43012119 |
132 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42806761 |
133 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42461602 |
134 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42316281 |
135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41400221 |
136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41142605 |
137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40780542 |
138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40463553 |
139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39442626 |
140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39081588 |
141 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37574266 |
142 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36792591 |
143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34080315 |